# Study of Rivaroxaban for CeREbral Venous Thrombosis

> **NCT03178864** · PHASE2 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 55 (actual)

## Conditions studied

- Cerebral Venous Thrombosis

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT03178864
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-12
- **Primary completion:** 2022-10-05
- **Final completion:** 2022-10-05
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2022-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03178864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03178864, "Study of Rivaroxaban for CeREbral Venous Thrombosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03178864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*